Profiles

Luke Bereznicki

UTAS Home Assoc Prof Luke Bereznicki
Luke Bereznicki

Luke Bereznicki

Deputy Head, School of Medicine
Associate Head, Pharmacy
Associate Professor in Pharmacy Practice

Pharmacy Building, Sandy Bay Campus

+61 3 6226 2195 (phone)

+61 3 6226 2870 (fax)

Luke.Bereznicki@utas.edu.au

Associate Professor Luke Bereznicki is a pharmacist with 12 years experience working in the health care sector, and has been an academic at the University of Tasmania since 2007. His career is dedicated to improving pharmacy practice in Australia through learning and teaching, research and advocacy. He provides leadership within the University of Tasmania as Associate Head of Discipline (Pharmacy) and Deputy Head of School (Medicine), and nationally within the pharmacy profession within a range of professional and industry bodies.

Career summary

Biography

Luke graduated from the University of Tasmania's Discipline of Pharmacy in 2002 with first class honours. In 2003, he was an inaugural recipient of a National Institute of Clinical Studies (now part of the NHMRC) PhD Scholarship. His research program was focused on the implementation of strategies to improve the quality use of anticoagulants in the hospital and community settings. He was appointed at the University of Tasmania's Pharmacy in 2007 and is currently Associate Professor in Pharmacy Practice. He is recognised as a leader in Australian pharmacy practice research and education, and has received a number of recent local and national awards recognising his work. He is dedicated to improving pharmacy practice in Australia through education, research and advocacy and was the 2008 Australian Young Pharmacist of the Year. In addition to his teaching and research activities, Luke is actively engaged in professional pharmacy practice; he works regularly in community pharmacy, writes regularly for the Australian Pharmacist and performs medication reviews and consultant pharmacist activities.

Luke's research has featured the implementation and evaluation of pharmacist involvement in a variety of quality improvement activities in both hospital and community settings. He is now recognised as one of the leading Australian authorities in this area and frequently speaks at conferences and provides education and training for health professionals and consumers. His research has been recognised nationally and internationally, and has resulted in a number of awards, including the following:

  • Inaugural National Institute of Clinical Studies PhD Scholarship (2004-2007)
  • Inaugural National Prescribing Service Student Quality Use of Medicine Award (2006)
  • Tasmanian and Australian Pearcey Award for Innovative and Pioneering Achievement and Contribution to Research and Development in Information Technology (2006)
  • Tasmanian Young Achiever in Science and Technology (2007) Dean of Graduate Research, (University of Tasmania)
  • Commendation for an outstanding doctoral thesis (2008)
  • Pharmaceutical Society of Australia Young Pharmacist of the Year (2008), Faculty of Health, University of Tasmania Rising Star (2009)
  • University of Tasmania Rising Star (2010)

Luke has published over 130 original and professional peer-reviewed papers and attracted over $6.5 million in competitive funding. Luke has strong links with the pharmacy profession and is a member of the Tasmanian Branch Committee of the Pharmaceutical Society of Australian (Tasmanian Branch) and former Board Director of the organisation. He is currently a Board Director of the Australian Association of Consultant Pharmacy.

Research Themes

Luke leads a group of researchers and students focused on improving the quality of anticoagulant use in primary and tertiary care settings. He has been committed to improving the use and management of anticoagulants in Australia since his early career. He also has a range of other research interests which share a common focus on improving medication safety and preventing adverse drug events.

Luke's research has had a major impact on shaping the future of his profession and improving the quality use of medicines, and is strongly aligned to the University's research theme of Better Health. He has led a range of research projects related to this theme, focussing on improving the management of a broad range of diseases, including respiratory disease, HIV, hypertension, acute coronary syndrome, pain, chronic kidney disease. He also leads a team of researchers and students focussed on the prevention of adverse drug events leading to hospitalisation.

Luke has been a Chief Investigator on several major national projects that have investigated and implemented new professional activities for Australian pharmacists. He was recently a lead investigator on a number of national projects (> $1.5M) funded by the Department of Health and Ageing which aimed to evaluate the role of pharmacists in providing education, support and ongoing monitoring for people taking anticoagulants in the community. He developed and maintains anticoagulation.com.au, a site that provides free educational resources about anticoagulant medications to consumers and health professionals.

Luke has an outstanding national reputation for his contributions within multidisciplinary research and quality improvement teams. The collective impact of his research and leadership in his field is evidenced by invitations to present at national and international conferences.

A major focus of his work has been on strategies to improve the quality use of anticoagulant medications in the elderly via a range of innovative strategies. These projects have focussed on both the community dwelling and institutionalised elderly. He has published widely in local and international journals on this topic. His innovative research in anticoagulation management is internationally recognised. His status within the field of anticoagulant medication research was acknowledged by appointment to the Commonwealth Government reference group on the 2012 Review of Anticoagulant Therapies in Atrial Fibrillation, which preceded the PBS-listing of novel anticoagulant medications for the prevention of stroke in AF in late-2013.

Luke currently leads the Tasmanian Atrial Fibrillation Study, which is investigating the use anticoagulant medications to prevent stroke in Tasmanians with Atrial Fibrillation from 2011 onwards. While research involving antithrombotic medications has been his major focus, Luke has also been involved in a number of other projects focused on improving the quality use of medicines in community and hospital settings. Other current areas of interest include the management of respiratory diseases, prevention of adverse drug reactions, pain management and medication adherence in a range of chronic conditions.

Memberships

Committee associations

  • Boehringer Ingelheim (BI) Advisory Board (2015 - present)
  • Chair, Scientific Advisory Committee, Australasian Pharmaceutical Science Association (2014-2015)
  • Practice Support and Education Committee (PSEC), Pharmaceutical Society of Australia (2014 - present)
  • Board Director, Australian Association of Consultant Pharmacists (2012-present)
  • Pharmaceutical Society of Australia (Tasmanian Branch) Committee Member (2008-present)
Former roles
  • Board Director, Pharmaceutical Society of Australia (2011-2015) 
  • National Chair, Practice Support and Education Committee (PSEC), Pharmaceutical Society of Australia (2014-2015)      
  • National Chair, Accredited Pharmacists Special Interest Group, Pharmaceutical Society of Australia (2011-2014)
  • Reference Group, Australian Government Review of Anticoagulant Therapies in Atrial Fibrillation (2011-2012)
  • Pharmaceutical Society of Australia (Tasmanian Branch) Committee Vice-President (2008-2013)
  • Pharmacy Board of Tasmania Graduate Accreditation Committee (2007-2009)
  • Pharmacy Board of Tasmania Competency Committee (2007-2009)

Other

Luke is currently a peer-reviewer for the following international journals:

  • Journal of Pharmacy Practice Research
  • Journal of Clinical Pharmacy and Therapeutics
  • Hematology
  • International Journal of General Medicine
  • Medical journal of Australia
  • Journal of Medical Internet Research

Teaching

Teaching expertise

Luke teaches a diverse range of topics related to pharmacy practice including ethics, law, quality use of medicines, communication, non-prescription medicines and the identification and resolution of drug-related problems. He currently coordinates the honours program within the Division of Pharmacy, and teaches into pharmacy practice and research methodology units.

Luke has demonstrated a strong commitment to research training and leadership through Research Higher Degree (RHD) supervision, mentoring of academics and the development of research curricula and processes. He has supervised RHD students through to completion. He also supervises a number of honours students each year.

Teaching responsibility

Luke commenced teaching at Pharmacy in 2007, and is now Associate Professor in Pharmacy Practice, Associate Head (Pharmacy) and Deputy Head of the School of Medicine. He teaches a diverse range of topics related to pharmacy practice including ethics, law, quality use of medicines, communication, non-prescription medicines and the identification and resolution of drug-related problems. He is also the Honours Co-ordinator.

View more on AssocProf Luke Bereznicki in WARP

Expertise

Associate Professor Bereznicki leads a group of researchers and students focused on improving the quality of anticoagulant use in primary and tertiary care settings. He has been committed to improving the use and management of anticoagulants in Australia since his early career. He also has a range of other research interests which share a common focus on improving medication safety and preventing adverse drug events.

Luke's research has had a major impact on shaping the future of his profession and improving the quality use of medicines. He has led a range of research projects related to this theme, focussing on improving the management of a broad range of diseases, including respiratory disease, HIV, hypertension, acute coronary syndrome, pain and chronic kidney disease. He also leads a team of researchers and students focussed on the prevention of adverse drug events leading to hospitalisation.

Luke has extensive experience in the following major research areas:

  • Clinical research
  • Implementation research
  • Clinical trials
  • Anticoagulation management
  • Pharmacy practice
  • Medication adherence
  • Chronic disease management

Awards

  • Inaugural National Prescribing Service Student Quality Use of Medicine Award (2006)
  • Tasmanian and Australian Pearcey Award for Innovative and Pioneering Achievement and
  • Contribution to Research and Development in Information Technology (2006)
  • Tasmanian Young Achiever in Science and Technology (2007)* Pharmaceutical Society of Australia Young Pharmacist of the Year (2008)
  • University of Tasmania Rising Star (2010)

Research Fields

  • Clinical Pharmacy and Pharmacy Practice (111503)
  • Pharmaceutical Sciences (111504)
  • Clinical Pharmacology and Therapeutics (111502)
  • Public Health and Health Services (111799)
  • Basic Pharmacology (111501)
  • Pharmacology and Pharmaceutical Sciences (111599)
  • Cardiology (incl. Cardiovascular Diseases) (110201)
  • Haematology (110202)
  • Health and Community Services (111708)
  • Health Information Systems (incl. Surveillance) (111711)
  • Preventive Medicine (111716)
  • Respiratory Diseases (110203)
  • Aged Health Care (111702)
  • Medicine, Nursing and Health Curriculum and Pedagogy (130209)
  • Residential Client Care (111718)
  • Paediatrics (111403)
  • Health Promotion (111712)
  • Health Care Administration (111709)
  • Health Counselling (111710)
  • Higher Education (130103)
  • Health Informatics (080702)
  • Nephrology and Urology (110312)
  • Primary Health Care (111717)
  • Pathology (110316)
  • Medical and Health Sciences (119999)
  • Pharmacogenomics (111505)
  • Cardiovascular Medicine and Haematology (110299)
  • Medical Biochemistry and Metabolomics (110199)
  • Public Nutrition Intervention (111104)
  • Orthopaedics (110314)
  • Interorganisational Information Systems and Web Services (080612)
  • Clinical Sciences (110399)

Research Impact

  • Health (929999)
  • Blood Disorders (920101)
  • Preventive Medicine (920412)
  • Cardiovascular System and Diseases (920103)
  • Clinical Health (Organs, Diseases and Abnormal Conditions) (920199)
  • Evaluation of Health Outcomes (920204)
  • Health Education and Promotion (920205)
  • Expanding Knowledge in the Medical and Health Sciences (970111)
  • Health and Support Services (920299)
  • Health Related to Ageing (920502)
  • Diabetes (920104)
  • Infectious Diseases (920109)
  • Respiratory System and Diseases (incl. Asthma) (920115)
  • Skeletal System and Disorders (incl. Arthritis) (920116)
  • Urogenital System and Disorders (920119)
  • Rural Health (920506)
  • Diagnostic Methods (920203)
  • Behaviour and Health (920401)
  • Assessment and Evaluation of Curriculum (930301)
  • Skin and Related Disorders (920117)
  • Health Policy Evaluation (920208)
  • Public Health (excl. Specific Population Health) (920499)
  • Cancer and Related Disorders (920102)
  • Child Health (920501)
  • Allied Health Therapies (excl. Mental Health Services) (920201)
  • Teaching and Instruction Technologies (930203)
  • Learner and Learning Processes (930102)
  • Digestive System Disorders (920105)
  • Neurodegenerative Disorders Related to Ageing (920112)
  • Carer Health (920202)
  • Nervous System and Disorders (920111)
  • Substance Abuse (920414)
  • Education and Training Systems (930599)
  • Nutrition (920411)
  • Information and Communication Services (899999)

Publications

Total publications

252

Journal Article

(149 outputs)
YearCitationAltmetrics
2016Alamneh EA, Chalmers L, Bereznicki LR, 'Suboptimal use of oral anticoagulants in atrial fibrillation: has the introduction of direct oral anticoagulants improved prescribing practices?', American journal of cardiovascular drugs : drugs, devices, and other interventions Article Epub ahead of print. ISSN 1175-3277 (2016) [Refereed Article]

DOI: 10.1007/s40256-016-0161-8 [eCite] [Details]

Co-authors: Chalmers L

Tweet

2016Bezabhe W, Chalmers L, Bereznicki LRE, Peterson GM, 'Adherence to Antiretroviral Therapy and Virologic Failure', Medicine, 95, (15) pp. 1-9. ISSN 0025-7974 (2016) [Refereed Article]

DOI: 10.1097/MD.0000000000003361 [eCite] [Details]

Co-authors: Bezabhe W; Chalmers L; Peterson GM

Tweet

2016Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?', Clinical and Applied Thrombosis - Hemostasis, April 12 ISSN 1076-0296 (2016) [Refereed Article]

DOI: 10.1177/1076029616642511 [eCite] [Details]

Co-authors: Bista D; Chalmers L; Peterson GM

Tweet

2016Frain BE, Castelino R, Bereznicki L, 'The Utilization of Antithrombotic Therapy in Older Australians With Atrial Fibrillation', Clinical and Applied Thrombosis - Hemostasis Article Epub ahead of print. ISSN 1076-0296 (2016) [Refereed Article]

DOI: 10.1177/1076029616637184 [eCite] [Details]

Co-authors: Frain BE; Castelino R

Tweet

2016Nair N, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, et al., 'Hospitalization in older patients due to adverse drug reactions - the need for a prediction tool', Clinical Interventions in Aging (Online), 11 pp. 497-505. ISSN 1178-1998 (2016) [Refereed Article]

DOI: 10.2147/CIA.S99097 [eCite] [Details]

Co-authors: Chalmers L; Peterson GM; Bereznicki BJ; Castelino RL

Tweet

2016Veal FC, Bereznicki LRE, Thompson AJ, Peterson GM, Orlikowski CE, 'Pain and Functionality Following Sternotomy: A Prospective 12-Month Observational Study', Pain Medicine pp. 1-8. ISSN 1526-2375 (2016) [Refereed Article]

DOI: 10.1093/pm/pnv066 [eCite] [Details]

Co-authors: Veal FC; Thompson AJ; Peterson GM

Tweet

2016Bezabhe WM, Chalmers L, Bereznicki LR, Gee P, Peterson GM, 'Antiretroviral adherence and treatment outcomes among adult Ethiopian patients', Aids Care: Psychological and Socio-Medical Aspects of Aids-Hiv ISSN 0954-0121 (2016) [Refereed Article]

DOI: 10.1080/09540121.2016.1139039 [eCite] [Details]

Co-authors: Bezabhe WM; Chalmers L; Gee P; Peterson GM

Tweet

2015Bereznicki LR, Van Tienen EC, Stafford A, 'Home medicines reviews in Australian war veterans taking warfarin do not influence International Normalised Ratio control', Internal Medicine Journal pp. 288-294. ISSN 1444-0903 (2015) [Refereed Article]

DOI: 10.1111/imj.12964 [eCite] [Details]

Co-authors: Van Tienen EC; Stafford A

Tweet

2015Bernal DDL, Bereznicki LRE, Chalmers L, Castelino RL, Thompson A, et al., 'Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?', American journal of cardiovascular drugs : drugs, devices, and other interventions ISSN 1175-3277 (2015) [Refereed Article]

DOI: 10.1007/s40256-015-0149-9 [eCite] [Details]

Co-authors: Bernal DDL; Chalmers L; Castelino RL; Thompson A; Peterson GM

Tweet

2015Bezabhe W, Bereznicki LRE, Chalmers L, Gee PR, Kassie DM, et al., 'Authors' Reply to Cotton and Nicol's Comment on Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia''', Drug Safety ISSN 0114-5916 (2015) [Letter or Note in Journal]

DOI: 10.1007/s40264-015-0335-3 [eCite] [Details]

Co-authors: Bezabhe W; Chalmers L; Gee PR; Peterson GM

Tweet

2015Bindoff I, Cummings EA, Ling TR, Chalmers L, Bereznicki LRE, 'Development of a Flexible and Extensible Computer-based Simulation Platform for Healthcare Students', Studies in Health Technology and Informatics, 208 pp. 83-86. ISSN 0926-9630 (2015) [Refereed Article]

DOI: 10.3233/978-1-61499-488-6-83 [eCite] [Details]

Co-authors: Bindoff I; Cummings EA; Ling TR; Chalmers L

Tweet

2015Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Patient Characteristics and Antithrombotic Prescribing Patterns in Patients With Atrial Fibrillation in Tasmania', Clinical and Applied Thrombosis - Hemostasis ISSN 1076-0296 (2015) [Refereed Article]

DOI: 10.1177/1076029615623375 [eCite] [Details]

Co-authors: Bista D; Chalmers L; Peterson GM

Tweet

2015Jose MD, Longmuir HD, Dodds B, Bereznicki L, Prasad R, et al., 'Anticoagulation for people receiving long-term haemodialysis', Cochrane Database of Systematic Reviews, (9) pp. 1-15. ISSN 1469-493X (2015) [Refereed Article]

DOI: 10.1002/14651858.CD011858 [eCite] [Details]

Co-authors: Jose MD; Dodds B

Tweet

2015Schmid OM, Chalmers L, Bereznicki LRE, 'Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart disease', Journal of Clinical Pharmacy and Therapeutics pp. 1-6. ISSN 0269-4727 (2015) [Refereed Article]

DOI: 10.1111/jcpt.12274 [eCite] [Details]

Co-authors: Schmid OM; Chalmers L

Tweet

2015Veal FC, Bereznicki LR, Thompson AJ, Peterson GM, Orlikowski C, 'Subacute Pain as a Predictor of Long-Term Pain Following Orthopedic Surgery: An Australian Prospective 12 Month Observational Cohort Study', Medicine (Baltimore): Analytical Reviews of General Medicine, Neurology, Psychiatry, Dermatology and Pediatrics, 94, (36) ISSN 0025-7974 (2015) [Refereed Article]

DOI: 10.1097/MD.0000000000001498 [eCite] [Details]

Co-authors: Veal FC; Thompson AJ; Peterson GM; Orlikowski C

Tweet

2015Veal FC, Bereznicki LRE, Thompson AJ, Peterson GM, 'Use of Opioid Analgesics in Older Australians', Pain Medicine, 16, (8) pp. 1519-27. ISSN 1526-4637 (2015) [Refereed Article]

DOI: 10.1111/pme.12720 [eCite] [Details]

Co-authors: Veal FC; Thompson AJ; Peterson GM

Tweet

2015Bereznicki BJ, Beggs S, Duff Caitlin, Bereznicki L, 'Adherence to management guidelines for childhood asthma in Australia', Australian Family Physician, 44, (12) pp. 933-938. ISSN 0300-8495 (2015) [Refereed Article]

[eCite] [Details]

Co-authors: Bereznicki BJ; Beggs S

2015Bezabhe W, Bereznicki LRE, Chalmers L, Gee P, Kassie DM, et al., 'Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study From Ethiopia', Drug Safety ISSN 0114-5916 (2015) [Refereed Article]

DOI: 10.1007/s40264-015-0295-7 [eCite] [Details]

Citations: Scopus - 2

Co-authors: Bezabhe W; Chalmers L; Gee P; Peterson GM

Tweet

2014Bernal D, Chalmers L, Bereznicki LRE, Castelino RL, Davidson PM, et al., 'An online person-centered education package for pharmacists delivering a home medication review service to patients following acute coronary syndromes', European Journal for Person Centered Healthcare, 2, (3) pp. 408-415. ISSN 2052-5656 (2014) [Refereed Article]

[eCite] [Details]

Co-authors: Bernal D; Chalmers L; Castelino RL; Davidson PM; Peterson GM

2014Bereznicki L, 'Novel oral anticoagulants in atrial fibrillation', Australian Pharmacist, 33, (10) pp. 62-66. ISSN 0728-4632 (2014) [Professional, Refereed Article]

[eCite] [Details]

2014Bereznicki L, 'Heart Failure', Australian Pharmacist, 33, (10) pp. 56-59. ISSN 0728-4632 (2014) [Professional, Refereed Article]

[eCite] [Details]

2014Bereznicki LRE, 'Anticoagulation in atrial fibrillation', Australian Pharmacist ISSN 0728-4632 (2014) [Professional, Refereed Article]

[eCite] [Details]

2014Bereznicki LRE, Jackson SL, Kromdijk W, Gee P, Fitzmaurice K, et al., 'Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study', International Journal of Pharmacy Practice, 22, (1) pp. 84-91. ISSN 0961-7671 (2014) [Refereed Article]

DOI: 10.1111/ijpp.12035 [eCite] [Details]

Co-authors: Jackson SL; Gee P; Fitzmaurice K; Bereznicki BJ; Peterson GM

Tweet

2014Bernal D, Bereznicki LRE, Peterson GM, 'With great power comes great responsibility', Medical Journal of Australia, 200, (6) pp. 321. ISSN 0025-729X (2014) [Letter or Note in Journal]

DOI: 10.5694/mja13.00061 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Bernal D; Peterson GM

Tweet

2014Bernal D, Bereznicki LRE, Peterson GM, 'Improving Medication Adherence and Helping Patients Make Lifestyle Changes', JAMA Internal Medicine, 174, (10) pp. 1707-8. ISSN 2168-6106 (2014) [Letter or Note in Journal]

DOI: 10.1001/jamainternmed.2014.669 [eCite] [Details]

Citations: Scopus - 1

Co-authors: Bernal D; Peterson GM

Tweet

2014Bereznicki LRE, 'Infective Conjunctivitis', Australian Pharmacist, 33, (10) pp. 62-66. ISSN 0728-4632 (2014) [Professional, Refereed Article]

[eCite] [Details]

2014Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, et al., 'Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia', PLoS One, 9, (5) Article e97353. ISSN 1932-6203 (2014) [Refereed Article]

DOI: 10.1371/journal.pone.0097353 [eCite] [Details]

Citations: Scopus - 10Web of Science - 11

Co-authors: Bezabhe WM; Chalmers L; Peterson GM

Tweet

2014Bindoff I, Ling T, Bereznicki L, Westbury J, Chalmers L, et al., 'A computer simulation of community pharmacy practice for educational use', American Journal of Pharmaceutical Education, 78, (9) Article 168. ISSN 0002-9459 (2014) [Refereed Article]

[eCite] [Details]

Co-authors: Bindoff I; Ling T; Westbury J; Chalmers L; Peterson G; Ollington R

2014Bista D, Chalmers L, Bereznicki L, Peterson G, 'Potential use of NOACs in developing countries: pros and cons', European Journal of Clinical Pharmacology, 70, (7) pp. 817-828. ISSN 1432-1041 (2014) [Refereed Article]

DOI: 10.1007/s00228-014-1693-y [eCite] [Details]

Citations: Scopus - 1Web of Science - 1

Co-authors: Bista D; Chalmers L; Peterson G

Tweet

2014Stewart K, George J, McNamara KP, Jackson SL, Peterson GM, et al., 'A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial)', Journal of Clinical Pharmacy and Therapeutics, 39, (5) pp. 527-534. ISSN 0269-4727 (2014) [Refereed Article]

DOI: 10.1111/jcpt.12185 [eCite] [Details]

Citations: Scopus - 4Web of Science - 2

Co-authors: Peterson GM; Gee PR

Tweet

2014Veal FC, Bereznicki LR, Thompson AJ, Peterson GM, 'Pharmacological management of pain in Australian Aged Care Facilities', Age and Ageing, 43, (6) pp. 851-856. ISSN 1468-2834 (2014) [Refereed Article]

DOI: 10.1093/ageing/afu072 [eCite] [Details]

Citations: Scopus - 1Web of Science - 3

Co-authors: Veal FC; Thompson AJ; Peterson GM

Tweet

2014Bereznicki L, 'Turning back time with botulinum toxin', Australian Pharmacist, 33, (7) pp. 62-65. ISSN 0728-4632 (2014) [Professional, Refereed Article]

[eCite] [Details]

2014Bereznicki LRE, 'Targeting medication review services', Australian Pharmacist pp. 24. ISSN 0728-4632 (2014) [Contribution to Refereed Journal]

[eCite] [Details]

2013Bereznicki L, 'Stroke prevention in atrial fibrillation: Novel anticoagulants', Australian Pharmacist, 32, (4) pp. 64-69. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

[eCite] [Details]

2013Bereznicki L, 'The role of newer antidepressants in treating major depression', Australian Pharmacist, 10, (32) pp. 60-65. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

[eCite] [Details]

2013Bereznicki L, Bereznicki B, 'Beta-blockers in asthma', Australian Pharmacist, 32, (5) pp. 54-57. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

[eCite] [Details]

Co-authors: Bereznicki B

2013Bereznicki L, Castelino R, 'Understanding randomised controlled trials', Australian Pharmacist, 32, (4) pp. 71-72. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

[eCite] [Details]

Co-authors: Castelino R

2013Bereznicki LRE, 'Melanoma', Australian Pharmacist, 32, (2) pp. 58-62. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

[eCite] [Details]

2013Bereznicki LRE, Castelino RL, 'Understanding Systematic Reviews', Australian Pharmacist, (August) pp. 68-69. ISSN 0728-4632 (2013) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Castelino RL

2013Bereznicki BJ, Norton LC, Beggs SA, Gee P, Bereznicki LRE, 'Review of the management of childhood asthma in Tasmania', Journal of Paediatrics and Child Health, 49, (8) pp. 678-683. ISSN 1034-4810 (2013) [Refereed Article]

DOI: 10.1111/jpc.12267 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Bereznicki BJ; Beggs SA; Gee P

Tweet

2013Bereznicki LRE, Madden A, Peterson GM, 'The quality of international normalised ratio control in southern Tasmania', Medical Journal of Australia, 198, (6) pp. 315. ISSN 0025-729X (2013) [Refereed Article]

DOI: 10.5694/mja12.11370 [eCite] [Details]

Co-authors: Madden A; Peterson GM

Tweet

2013Bezabhe WM, Peterson GM, Bereznicki L, Chalmers L, Gee P, 'Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol', BMJ Open, 3, (10) Article e003559. ISSN 2044-6055 (2013) [Contribution to Refereed Journal]

DOI: 10.1136/bmjopen-2013-003559 [eCite] [Details]

Citations: Scopus - 2Web of Science - 3

Co-authors: Bezabhe WM; Peterson GM; Chalmers L; Gee P

Tweet

2013Castelino R, Bereznicki L, 'Understanding non-randomised study designs', Australian Pharmacist, 32, (6) pp. 63-64. ISSN 0728-4632 (2013) [Contribution to Refereed Journal]

[eCite] [Details]

Co-authors: Castelino R

2013Castelino RL, Bereznicki LRE, 'The basics of evidence-based medicine', Australian Pharmacist, 32, (2) pp. 72-74. ISSN 0728-4632 (2013) [Refereed Article]

[eCite] [Details]

Co-authors: Castelino RL

2013Castelino RL, Bereznicki LRE, 'How to read and interpret clinical trials', Australian Pharmacist, 32, (10) pp. 68-69. ISSN 0728-4632 (2013) [Non Refereed Article]

[eCite] [Details]

Co-authors: Castelino RL

2013Mirkazemi C, Bereznicki LR, Peterson GM, 'Thromboprophylaxis following hip and knee arthroplasty', Internal Medicine Journal, 43, (2) pp. 124-129. ISSN 1444-0903 (2013) [Refereed Article]

DOI: 10.1111/j.1445-5994.2013.02864.x [eCite] [Details]

Citations: Scopus - 3

Co-authors: Mirkazemi C; Peterson GM

Tweet

2013Mirkazemi C, Bereznicki LRE, Peterson GM, 'Response to Re: Are the national orthopaedic thromboprophylaxis guidelines appropriate?', ANZ Journal of Surgery, 83, (5) pp. 395-396. ISSN 1445-1433 (2013) [Letter or Note in Journal]

DOI: 10.1111/ans.12119 [eCite] [Details]

Co-authors: Mirkazemi C; Peterson GM

Tweet

2013Bereznicki LRE, Jackson SL, Peterson GM, 'Supervised patient self-testing of Warfarin therapy using an online system', Journal of Medical Internet Research, 15, (7) Article e138. ISSN 1439-4456 (2013) [Refereed Article]

DOI: 10.2196/jmir.2255 [eCite] [Details]

Citations: Scopus - 3Web of Science - 3

Co-authors: Jackson SL; Peterson GM

Tweet

2012Bereznicki L, 'Head Lice', Australian Pharmacist, 31, (2) pp. 142-146. ISSN 0728-4632 (2012) [Professional, Refereed Article]

[eCite] [Details]

2012Bereznicki L, 'Factors affecting wound healing', Australian Pharmacist, 31, (6) pp. 484-487. ISSN 0728-4632 (2012) [Professional, Refereed Article]

[eCite] [Details]

2012Bereznicki L, 'Post traumatic stress disorder', Australian Pharmacist, (September 2012) pp. 738 - 741. ISSN 0728-4632 (2012) [Professional, Refereed Article]

[eCite] [Details]

2012Bereznicki L, 'Eating Disorders', Australian Pharmacist, (December 2012) pp. 968-972. ISSN 0728-4632 (2012) [Professional, Refereed Article]

[eCite] [Details]

2012Bereznicki LRE, 'Changes to HMR business rules', Australian Pharmacist, 31, (3) pp. 186. ISSN 0728-4632 (2012) [Professional, Non Refereed Article]

[eCite] [Details]

2012Bereznicki LRE, 'Managing glycaemia in type 2 diabetes', Australian Pharmacist, (July) pp. 566 - 570. ISSN 0728-4632 (2012) [Professional, Refereed Article]

[eCite] [Details]

2012Bernal DDL, Stafford L, Bereznicki LRE, Castelino RL, Davidson PM, et al., 'Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial', Trials, 13, (30) pp. 1-17. ISSN 1745-6215 (2012) [Refereed Article]

DOI: 10.1186/1745-6215-13-30 [eCite] [Details]

Citations: Scopus - 2Web of Science - 2

Co-authors: Bernal DDL; Stafford L; Castelino RL; Peterson GM

Tweet

2012Mirkazemi C, Bereznicki LR, Peterson GM, 'Are the national orthopaedic thromboprophylaxis guidelines appropriate?', ANZ Journal of Surgery, 82, (12) pp. 913-917. ISSN 1445-1433 (2012) [Refereed Article]

DOI: 10.1111/j.1445-2197.2012.06203.x [eCite] [Details]

Citations: Scopus - 5Web of Science - 4

Co-authors: Mirkazemi C; Peterson GM

Tweet

2012Peterson GM, Stafford L, Van Tienen E, Bereznicki L, 'Anticoagulant therapy in the elderly: the importance of health literacy', Australian Pharmacist, 31, (1) pp. 32-34. ISSN 0728-4632 (2012) [Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM; Stafford L; Van Tienen E

2012Stafford L, Van Tienen EC, Bereznicki LRE, Peterson GM, 'The benefits of pharmacist-delivered warfarin education in the home', International Journal of Pharmacy Practice, 20, (6) pp. 384-389. ISSN 0961-7671 (2012) [Refereed Article]

DOI: 10.1111/j.2042-7174.2012.00217.x [eCite] [Details]

Citations: Scopus - 1

Co-authors: Stafford L; Van Tienen EC; Peterson GM

Tweet

2012Stafford L, Van Tienen EC, Peterson GM, Bereznicki LRE, Jackson SL, et al., 'Warfarin management after discharge from hospital: a qualitative analysis', Journal of Clinical Pharmacy and Therapeutics, 37, (4) pp. 410-414. ISSN 0269-4727 (2012) [Refereed Article]

DOI: 10.1111/j.1365-2710.2011.01308.x [eCite] [Details]

Citations: Scopus - 3Web of Science - 1

Co-authors: Stafford L; Van Tienen EC; Peterson GM; Jackson SL

Tweet

2012Bereznicki L, 'Antibiotics for acute otitis media in children', Australian Pharmacist, 31, (4) pp. 308-310. ISSN 0728-4632 (2012) [Professional, Refereed Article]

[eCite] [Details]

2011Singh P, Arrevad PS, Peterson GM, Bereznicki LR, 'Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities', Journal of Clinical Pharmacy and Therapeutics, 36, (2) pp. 166-171. ISSN 0269-4727 (2011) [Refereed Article]

DOI: 10.1111/j.1365-2710.2010.01167.x [eCite] [Details]

Citations: Scopus - 6Web of Science - 3

Co-authors: Peterson GM

Tweet

2011Bereznicki LRE, 'Urinary incontinence', Australian Pharmacist, 30, (4) pp. 318-322. ISSN 0728-4632 (2011) [Professional, Non Refereed Article]

[eCite] [Details]

2011Bereznicki LRE, 'Rheumatoid Arthritis', Australian Pharmacist, 30, (10) pp. 858-863. ISSN 0728-4632 (2011) [Professional, Non Refereed Article]

[eCite] [Details]

2011Bereznicki LRE, 'Xerostomia', Australian Pharmacist, 30, (12) pp. 1022-1025. ISSN 0728-4632 (2011) [Professional, Non Refereed Article]

[eCite] [Details]

2011Bereznicki LRE, Thompson AJ, 'Medicine-induced pulmonary toxicity', Australian Pharmacist, 30, (6) pp. 494-498. ISSN 0728-4632 (2011) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Thompson AJ

2011Bereznicki LRE, 'Fungal foot infections', Australian Pharmacist, 30, (8) pp. 670-674. ISSN 0728-4632 (2011) [Professional, Non Refereed Article]

[eCite] [Details]

2011Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, 'A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study', BMC Health Services Research, 11, (16) pp. 1-11. ISSN 1472-6963 (2011) [Contribution to Refereed Journal]

DOI: 10.1186/1472-6963-11-16 [eCite] [Details]

Citations: Scopus - 3Web of Science - 2

Co-authors: Stafford L; Peterson GM; Jackson SL

Tweet

2011Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Van Tienen EC, et al., 'Clinical Outcomes of a Collaborative, Home-Based Postdischarge Warfarin Management Service', The Annals of Pharmacotherapy, 45, (3) pp. 325-334. ISSN 1060-0280 (2011) [Refereed Article]

DOI: 10.1345/aph.1P617 [eCite] [Details]

Citations: Scopus - 16Web of Science - 9

Co-authors: Stafford L; Peterson GM; Jackson SL; Van Tienen EC

Tweet

2011Stafford L, Stafford A, Hughes J, Angley M, Bereznicki L, et al., 'Drug-related problems identified in post-discharge medication reviews for patients taking warfarin', International Journal of Clinical Pharmacy, 33, (4) pp. 621-626. ISSN 2210-7703 (2011) [Refereed Article]

DOI: 10.1007/s11096-011-9515-0 [eCite] [Details]

Citations: Scopus - 13Web of Science - 6

Co-authors: Stafford L; Stafford A; Hughes J; Peterson G

Tweet

2011Williams M, Peterson GM, Tenni PC, Bindoff IK, Curtain C, et al., 'Drug-Related Problems Detected in Australian Community Pharmacies: The PROMISe Trial', The Annals of Pharmacotherapy, 45, (9) pp. 1067-1076. ISSN 1542-6270 (2011) [Refereed Article]

DOI: 10.1345/aph.1Q138 [eCite] [Details]

Citations: Scopus - 14Web of Science - 9

Co-authors: Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Jackson SL

Tweet

2011Bereznicki LRE, 'Primary open-angle glaucoma', Australian Pharmacist, 30, (2) pp. 140-146. ISSN 0728-4632 (2011) [Professional, Non Refereed Article]

[eCite] [Details]

2010Bereznicki L, 'Managing attention deficit hyperactivity disorder in children', Australian Pharmacist, 29, (4 ) pp. 331-335. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

2010Bereznicki L, 'Incretin-based therapies', Australian Pharmacist, 29, (6) pp. 508-513. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

2010Bereznicki L, 'Management of hypertension', Australian Pharmacist, 29, (10) pp. 872-878. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

2010Bereznicki L, 'Hormone replacement therapy for menopause', Australian Pharmacist, 29, (2) pp. 148-152. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

2010Bereznicki L, 'Dopamine agonists in Parkinson's disease', Australian Pharmacist, 29, (12) pp. 1056-1062. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

2010Bereznicki L, Bereznicki BJ, 'Inhaled anticholinergic medications: their role in COPD and adverse cardiovascular events', Australian Pharmacist, 29, (8) pp. 690-694. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Bereznicki BJ

2010Bereznicki LRE, Peterson GM, 'New antithrombotics for Atrial Fibrillation', Cardiovascular Therapeutics, 28, (5) pp. 278-286. ISSN 1755-5914 (2010) [Refereed Article]

DOI: 10.1111/j.1755-5922.2010.00209.x [eCite] [Details]

Citations: Scopus - 18Web of Science - 15

Co-authors: Peterson GM

Tweet

2010Luinstra M, Naunton M, Peterson GM, Bereznicki L, 'PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation', Journal of Clinical Pharmacy and Therapeutics, 35, (2) pp. 213-217. ISSN 0269-4727 (2010) [Refereed Article]

DOI: 10.1111/j.1365-2710.2009.01089.x [eCite] [Details]

Citations: Scopus - 12Web of Science - 8

Co-authors: Peterson GM

Tweet

2010Peterson GM, Bereznicki L, 'Therapeutic catch 22 - Warfarin use in the elderly', Australian Pharmacist, 29, (3) pp. 246-250. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2010Peterson GM, Stafford L, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Point-of-care testing', Australian Prescriber, 33, (6) pp. 167-168. ISSN 0312-8008 (2010) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Peterson GM; Stafford L; Van Tienen EC; Jackson SL

2010Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Van Tienen EC, 'Training Australian pharmacists for participation in a collaborative, home-based post-discharge warfarin management service', Pharmacy World & Science, 32, (5) pp. 637-642. ISSN 0928-1231 (2010) [Refereed Article]

DOI: 10.1007/s11096-010-9416-7 [eCite] [Details]

Citations: Scopus - 4Web of Science - 3

Co-authors: Stafford L; Peterson GM; Jackson SL; Van Tienen EC

Tweet

2010Stafford L, Van Tienen EC, Bereznicki L, Peterson GM, 'Anticoagulation monitoring services', Australian Pharmacist, 29, (3) pp. 221-225. ISSN 0728-4632 (2010) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Stafford L; Van Tienen EC; Peterson GM

2009Bereznicki BJ, Bereznicki LRE, 'When asthma and COPD overlap each other', Australian Pharmacist, 28, (9) pp. 782-786. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Bereznicki BJ

2009Bereznicki LRE, 'Non-melanoma skin cancer', Australian Pharmacist, 28, (3) pp. 240-245. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

2009Bereznicki LRE, 'Antioxidants and the prevention of cancer', Australian Pharmacist, 28, (8) pp. 686-691. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

2009Bereznicki LRE, 'Clopidogrel and PPIs: what is the current evidence?', Australian Pharmacist, 28, (11) pp. 943. ISSN 0728-4632 (2009) [Letter or Note in Journal]

[eCite] [Details]

2009Bereznicki LRE, 'Calcium and vitamin D in osteoporosis', Australian Pharmacist, 28, (12) pp. 1064-1070. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

2009Bereznicki LRE, Peterson GM, 'Medications used in assisted reproduction', Australian Pharmacist, 28 , (1) pp. 60-62. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2009Bereznicki LRE, Peterson GM, 'Multimorbidity and the elderly', Australian Pharmacist, 28, (11) pp. 978-983. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2009Bereznicki LRE, Stafford L, Jeffrey EC, Peterson GM, Jackson SL, 'Who is responsible for the care of patients treated with warfarin therapy?', The Medical Journal of Australia, 191, (10) pp. 575-576. ISSN 0025-729X (2009) [Letter or Note in Journal]

[eCite] [Details]

Citations: Scopus - 2

Co-authors: Stafford L; Jeffrey EC; Peterson GM; Jackson SL

2009Jeffrey EC, Bereznicki LRE, 'Infant formulas', Australian Pharmacist, 28, (2) pp. 140-144. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jeffrey EC

2009Jeffrey EC, Bereznicki LRE, 'Inflammatory bowel disease', Australian Pharmacist, 28, (6) pp. 504-509. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jeffrey EC

2009Luinstra M, Naunton M, Peterson GM, Bereznicki LRE, 'Clopidogrel prescribing and concordance with the Pharmaceutical Benefits Scheme in hospital patients', Journal of Pharmacy Practice and Research , 39, (4) pp. 265-268. ISSN 1445-937X (2009) [Refereed Article]

[eCite] [Details]

Co-authors: Luinstra M; Peterson GM

2009Stafford AC, Bereznicki LRE, 'Prevention and treatment of drug-resistant Staphylococcus aureus', Australian Pharmacist, 28, (4) pp. 332-337. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Stafford AC

2009Stafford L, Bereznicki LRE, 'Statins as primary prevention in patients without dislipidaemia', Australian Pharmacist, 28, (5) pp. 422-426. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Stafford L

2009Williams Mackenzie, Peterson GM, Tenni PC, Bereznicki LRE, 'PROMISe to document clinical interventions in Australian community pharmacies', Australian Pharmacist, 28, (2) pp. 162-164. ISSN 0728-4632 (2009) [Refereed Article]

[eCite] [Details]

Co-authors: Williams Mackenzie; Peterson GM; Tenni PC

2009Bereznicki LRE, 'Glycaemic control in type 2 diabetes: what is the target?', Australian Pharmacist, 28, (7) pp. 596-601. ISSN 0728-4632 (2009) [Professional, Non Refereed Article]

[eCite] [Details]

2008Bereznicki LRE, Peterson GM, 'Weight management', Australian Pharmacist, 27, (8) pp. 658-663. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki BJ, Bereznicki LRE, Peterson GM, 'Strategies to manage COPD', Australian Pharmacist, 27, (6) pp. 485-491. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Bereznicki BJ; Peterson GM

2008Bereznicki LRE, Peterson GM, 'New medications to treat type 2 diabetes', Australian Pharmacist, 27, (3) pp. 246-251. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki LRE, Peterson GM, 'Adverse drug events and the role of the pharmacy', Australian Pharmacist, 27, (9) pp. 750-756. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki LRE, Peterson GM, 'External ear problems', Australian Pharmacist, 27, (10) pp. 838-847. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki LRE, Peterson GM, 'Statins in the elderly', Australian Pharmacist, 27, (7) pp. 579-584. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki LRE, 'Very-low calorie diets: a review of the evidence', Australian Pharmacist, 27, (9) pp. 724-727. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

2008Bereznicki LRE, Peterson GM, 'Vitamin supplements in the elderly', Australian Pharmacist, 27, (12) pp. 1010-1014. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki LRE, Peterson GM, 'Bisphosphonates and osteomyelitis of the jaw', Australian Pharmacist, 27, (11) pp. 927-931. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Jackson SL, Bereznicki LRE, Peterson GM, Jeffrey EC, 'An update on INR monitoring', Australian Pharmacist, 27, (7) pp. 562-564. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Jeffrey EC

2008Nash RE, Bereznicki LRE, Peterson GM, 'Smoking cessation', AusPharm Continuing Education pp. 1-8. (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Nash RE; Peterson GM

2008Peterson GM, Bereznicki LRE, 'Recent issues with paracetamol: don't throw the baby out with the bathwater', Australian Pharmacist, 27, (11) pp. 900-901. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2008Bereznicki BJ, Bereznicki LRE, Peterson GM, 'Strategies to manage asthma', Australian Pharmacist, 27, (5) pp. 414-418. ISSN 0728-4632 (2008) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Bereznicki BJ; Peterson GM

2007Bereznicki BJ, Bereznicki LRE, Peterson GM, Peterson GM, 'How can pharmacists improve asthma control in the community?', Australian Pharmacist, 26, (7) pp. 566-567. ISSN 0728-4632 (2007) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Bereznicki BJ; Peterson GM; Peterson GM

2007Bereznicki LRE, Jackson SL, 'Comment: Increased sensitivity to warfarin after heart valve replacement', The Annals of Pharmacotherapy, 40, (7) pp. 1476-1477. ISSN 1060-0280 (2007) [Letter or Note in Journal]

DOI: 10.1345/aph.1G407a [eCite] [Details]

Co-authors: Jackson SL

Tweet

2007Bereznicki LRE, Jackson SL, Morgan SO, Boland C, Marsden KA, et al., 'Improving clinical outcomes for hospital patients initiated on warfarin', Journal of Pharmacy Practice and Research, 37, (4) pp. 295-302. ISSN 1445-937X (2007) [Refereed Article]

[eCite] [Details]

Citations: Scopus - 3

Co-authors: Jackson SL; Marsden KA; Jupe DML; Vial JH; Peterson GM

2007Bereznicki LRE, Jackson SL, Peterson GM, 'Substituting phenylephrine for pseudoephedrine as a nasal decongestant: is it evidence-based?', Australian Pharmacist, 26, (4) pp. 298-299. ISSN 0728-4632 (2007) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2007Bereznicki LRE, Jackson SL, Peterson GM, 'Encouraging the rational use of probiotics in combination with antibiotics - what are we trying to prevent?', Australian Pharmacist, 26, (1) pp. 26. ISSN 0728-4632 (2007) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2007Bereznicki LRE, Jackson SL, Peterson GM, 'Improving aspirin use among adults with diabetes', Australian Pharmacist, 26, (6) pp. 458459. ISSN 0728-4632 (2007) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2007Bereznicki LRE, Jackson SL, Peterson GM, 'Coenzyme Q10 and statin-associated myopathy', Australian Pharmacist, 26, (10) pp. 794. ISSN 0728-4632 (2007) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2007Bereznicki LRE, Jackson SL, Peterson GM, Jeffrey EC, Marsden KA, et al., 'Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring', Journal of Clinical Pathology, 60, (60) pp. 311-314. ISSN 0021-9746 (2007) [Refereed Article]

DOI: 10.1136/jcp.2006.037820 [eCite] [Details]

Citations: Scopus - 51Web of Science - 39

Co-authors: Jackson SL; Peterson GM; Jeffrey EC; Marsden KA; Jupe DML

Tweet

2007Bereznicki LRE, Peterson GM, 'Warfarin management in Australia: what can pharmacists offer?', Australian Pharmacist, 26, (12) pp. 954-955. ISSN 0728-4632 (2007) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM

2006Bereznicki LRE, Jackson SL, Peterson GM, 'Encouraging periconceptional use of folic acid supplements', Australian Pharmacist, 25, (9) pp. 706. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Bereznicki LR, Peterson GM, Jackson SL, Jeffrey EC, 'The risks of warfarin use in the elderly', Expert Opinion on Drug Safety, 5, (3) pp. 417-431. ISSN 1474-0338 (2006) [Refereed Article]

DOI: 10.1517/14740338.5.3.417 [eCite] [Details]

Citations: Scopus - 13Web of Science - 7

Co-authors: Peterson GM; Jackson SL; Jeffrey EC

Tweet

2006Bereznicki LRE, Jackson SL, Peterson GM, 'Combining aspirin and clopidogrel: when is one better than both?', Australian Pharmacist, 25, (6) pp. 480. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Bereznicki LRE, Jackson SL, Peterson GM, 'Preventing age-related macular degeneration', Australian Pharmacist, 25, (3) pp. 244. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Bereznicki LRE, Jackson SL, Peterson GM, 'Ximelagatran cost effectiveness for stroke prevention in atrial fibrillation', Journal of Pharmacy Practice and Research, 36, (2) pp. 162. ISSN 1445-937X (2006) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Bereznicki LRE, Jackson SL, Peterson GM, 'Which is the safest NSAID for patients at elevated cardiovascular risk?', Australian Pharmacist, 25, (11) pp. 853. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Bereznicki LRE, Jackson SL, Jeffrey EC, Peterson GM, 'Home-monitoring of warfarin (the ultimate strategy to improve the safety of anticoagulation)', Australian Pharmacist, 25, (3) pp. 246-251. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Jeffrey EC; Peterson GM

2006Bereznicki LRE, Jackson SL, Peterson GM, 'Preventing age-related macular degeneration', Australian Pharmacist, 25, (3) pp. 244-245. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Jackson SL, Bereznicki LRE, Peterson GM, 'Preventing osteoporosis-related fractures', Australian Pharmacist, 25, (4) pp. 318. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Jackson SL, Bereznicki LRE, Peterson GM, 'Hypertension', Australian Pharmacist, 25, (2) pp. 158. ISSN 0728-4632 (2006) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2006Peterson GM, Bereznicki LRE, 'Multivitamins and breast cancer risk - no need to panic', Australian Pharmacist, 29, (6) pp. 444. ISSN 0728-4632 (2006) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Peterson GM

2006Peterson GM, Jackson SL, Bereznicki LRE, 'Evidence-practice gaps', Australian Pharmacist, 25, (1) pp. 6. ISSN 0728-4632 (2006) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL

2006Bereznicki LRE, Jackson SL, 'Comment: Increased sensitivity to warfarin after heart valve replacement', The Annals of Pharmacotherapy, 40, (7) pp. 1476-1477. ISSN 1060-0280 (2006) [Letter or Note in Journal]

DOI: 10.1345/aph.1G407a [eCite] [Details]

Co-authors: Jackson SL

Tweet

2005Bereznicki LRE, Jackson SL, Peterson GM, 'The direct thrombin inhibitor melagatran/ximelagatran', Medical Journal of Australia, 182, (5) pp. 254-255. ISSN 0025-729X (2005) [Letter or Note in Journal]

[eCite] [Details]

Citations: Scopus - 3

Co-authors: Jackson SL; Peterson GM

2005Bereznicki LRE, Jackson SL, Peterson GM, 'Closing the gap between evidence and practice', Journal of Pharmacy Practice and Research, 35, (3) pp. 173-176. ISSN 1445-937X (2005) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Bereznicki LRE, Peterson GM, Jackson SL, 'Venous thromboembolism: under-use of prophylaxis for medical and nursing home patients', Australian Pharmacist, 24, (5) pp. 402-404. ISSN 0728-4632 (2005) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL

2005Jackson SL, Bereznicki LRE, Peterson GM, 'An important role for community pharmacy in reducing evidence gaps', Australian Pharmacist, 24, (7) pp. 558. ISSN 0728-4632 (2005) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Jackson SL, Bereznicki LRE, Peterson GM, 'Under-use of B-Blockers', Australian Pharmacist, 24, (9) pp. 691. ISSN 0728-4632 (2005) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Jackson SL, Bereznicki LRE, Peterson GM, 'Hypertension', Australian Pharmacist, 25, (2) pp. 158139. ISSN 0728-4632 (2005) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Jackson SL, Bereznicki LRE, Peterson GM, 'Under-use of ACE-inhibitor and B-Blocker therapies in congestive cardiac failure', Australian Pharmacist, 24, (12) pp. 936. ISSN 0728-4632 (2005) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Jackson SL, Bereznicki LRE, Peterson GM, 'Over-use of antibiotics for acute otitis media', Australian Pharmacist, 24, (10) pp. 200. ISSN 0728-4632 (2005) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Jackson SL, Peterson GM, Bereznicki LRE, 'Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR', American Heart Journal, 149, (1) pp. E1. ISSN 0002-8703 (2005) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2005Jackson SL, Peterson GM, Bereznicki LRE, Misan GM, Jupe DML, et al., 'Improving the outcomes of anticoagulation in rural Australia: An evaluation of pharmacist-assisted monitoring of warfarin therapy', Journal of Clinical Pharmacy and Therapeutics, 30, (4) pp. 345-353. ISSN 0269-4727 (2005) [Refereed Article]

DOI: 10.1111/j.1365-2710.2005.00656.x [eCite] [Details]

Citations: Scopus - 18Web of Science - 11

Co-authors: Jackson SL; Peterson GM; Jupe DML; Vial JH

Tweet

2005Naunton M, Peterson GM, Bereznicki LRE, Jackson SL, 'The enigma of aspirin in primary prevention', Australian Pharmacist, 24, (9) pp. 718-722. ISSN 0728-4632 (2005) [Professional, Non Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL

2005Peterson GM, Bereznicki LRE, 'Protection of the public or protection of the pharmaceutical industry?', Australian Prescriber, 28, (4) pp. 86. ISSN 0312-8008 (2005) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Peterson GM

2005Peterson GM, Jackson SL, Bereznicki LRE, 'Evidence-practice gaps', Australian Pharmacist, 25, (1) pp. 6. ISSN 0728-4632 (2005) [Letter or Note in Journal]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL

2004Jackson SL, Bereznicki LRE, Peterson GM, Marsden KA, Jupe DML, et al., 'Accuracy and clinical usefulness of the near-patient testing CoaguChek S international normalised ratio monitor in rural medical practice', Australian Journal of Rural Health, 12, (4) pp. 137-142. ISSN 1038-5282 (2004) [Refereed Article]

DOI: 10.1111/j.1440-1854.2004.00585.x [eCite] [Details]

Citations: Scopus - 22

Co-authors: Jackson SL; Peterson GM; Marsden KA; Vial JH

Tweet

2004Jackson SL, Bereznicki LRE, Peterson GM, Marsden KA, Jupe DML, et al., 'Accuracy, reproducibility and clinical utility of the CoaguChek S portable international normalized ratio monitor in an outpatient anticoagulation clinic', Clinical and Laboratory Haematology, 26, (1) pp. 49-55. ISSN 0141-9854 (2004) [Refereed Article]

DOI: 10.1111/j.0141-9854.2003.00578.x [eCite] [Details]

Citations: Scopus - 22Web of Science - 17

Co-authors: Jackson SL; Peterson GM; Marsden KA; Tegg EM; Vial JH; Kimber R

Tweet

2002Peterson GM, Jackson SL, Bereznicki LRE, 'Stroke prevention - anticoagulation for atrial fibrillation', Australian Pharmacist, 21, (3) pp. 203-206. ISSN 0728-4632 (2002) [Refereed Article]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL

Book

(3 outputs)
YearCitationAltmetrics
2015Bereznicki LRE, 'Antithrombotics Essential CPE', Pharmaceutical Society of Australia Ltd., Australia, pp. 50. (2015) [Revision/New Edition]

[eCite] [Details]

2013Bereznicki LRE, Thompson M, Sussman G, Greig L, 'Wound Care in Practice', Pharmaceutical Society of Australia Ltd, Australia, pp. 80. (2013) [Authored Other Book]

[eCite] [Details]

2009Bereznicki LRE, 'Anti-thrombotics Essential CPE- Continuing education from the Pharmaceutical Society of Australia', Pharmaceutical Society of Australia, ACT, pp. 1-72. ISBN 978-0-9807235-0-2 (2009) [Authored Other Book]

[eCite] [Details]

Chapter in Book

(1 outputs)
YearCitationAltmetrics
2011Bereznicki LRE, 'Dabigatran (Pradaxa) for atrial fibrillation', Annual Medicines Update 2011, Pharmaceutical Society of Australia, Marnie Firipis (ed), Deakin ACT, Australia, pp. 20-24. ISBN 978-0-9807235-6-4 (2011) [Other Book Chapter]

[eCite] [Details]

Conference Publication

(98 outputs)
YearCitationAltmetrics
2015Obamiro K, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulant knowledge instrument', APSA-ASCEPT 2015, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L

2015Bereznicki BJ, Walters EH, Walters JAE, Peterson GM, Bereznicki LRE, 'Diagnosis and management of early COPD in Australia: views from the coal face', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bereznicki BJ; Walters EH; Walters JAE; Peterson GM

2015Bezabhe W, Chalmers L, Bereznicki LRE, Gee PR, Peterson GM, 'Antiretroviral adherence and treatment outcomes among adult Ethiopian patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bezabhe W; Chalmers L; Gee PR; Peterson GM

2015Bindoff IK, Ling TR, Bereznicki LRE, Chalmers L, Westbury JL, 'Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bindoff IK; Ling TR; Chalmers L; Westbury JL

2015Bindoff IK, Ling TR, Bereznicki LRE, Chalmers L, Westbury JL, et al., 'Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists', Pharmacy Simulator: A 3D computer-based virtual patient simulator for training community pharmacists, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bindoff IK; Ling TR; Chalmers L; Westbury JL; Gee PR; Garland T

2015Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bista D; Chalmers L; Peterson GM

2015Bista D, Chalmers L, Peterson GM, Bereznicki LRE, 'Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bista D; Chalmers L; Peterson GM

2015Chalmers L, Bereznicki LRE, Prasad R, Hancock N, MacIntyre PD, et al., 'SMART-AF: Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Frain BE

2015Chalmers L, Bereznicki LRE, Prasad Ritam, Hancock N, MacIntyre PD, et al., 'SMART-AF: Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Prasad Ritam; Frain BE

2015Chalmers L, Scott BE, Curtain CM, Bereznicki LRE, 'Tasmanian hospital clinicians' attitudes regarding stroke prevention in atrial', Medicines Management 2015: The 41st SHPA National Conference, 3-6 December, 2015, Melbourne, Australia, pp. 82. (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Curtain CM

2015Chapman M, Bereznicki BJ, Bereznicki LRE, 'Understanding the discrepancy between perceived and actual asthma control in Australia', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bereznicki BJ

2015Nair N, Chalmers L, Bereznicki BJ, Castelino RL, Peterson GM, et al., 'Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Bereznicki BJ; Castelino RL; Peterson GM; Curtain CM; Connolly MJ

2015Nair N, Chalmers L, Bereznicki BJ, Peterson GM, Curtain CM, et al., 'Development of a Score to Predict Hospitalisation due to Adverse Drug Reactions in Older Patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Bereznicki BJ; Peterson GM; Curtain CM; Connolly MJ

2015Obamiro K, Chalmers L, Bereznicki LRE, 'Development and validation of an oral anticoagulant knowledge instrument', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L

2015Bezabhe W, Chalmers L, Bereznicki LRE, Gee PR, Peterson GM, 'Antiretroviral adherence and treatment outcomes among adult Ethiopian patients', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bezabhe W; Chalmers L; Gee PR; Peterson GM

2015Scott BE, Curtain CM, Chalmers L, Bereznicki LRE, 'Clinicians' attitudes and perceptions regarding stroke prevention in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Curtain CM; Chalmers L

2015Scott BE, Curtain CM, Chalmers L, Bereznicki LRE, 'Clinicians' attitudes and perceptions regarding stroke prevention in atrial fibrillation', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Curtain CM; Chalmers L

2015Bernal D, Chalmers L, Castelino RL, Bereznicki LRE, Peterson GM, 'Home Medicines Review following acute coronary syndromes: Preliminary results from a randomised controlled trial', 2015 Joint APSA-ASCEPT Annual Conference, 29 November - 2 December, 2015, Hobart, Tasmania (2015) [Conference Extract]

[eCite] [Details]

Co-authors: Bernal D; Chalmers L; Castelino RL; Peterson GM

2014Chalmers L, Nash RE, Holmes SE, Bereznicki LRE, Cooper J, et al., 'Development of a benchmarking tool for pharmacy students using threshold learning outcomes', APSA 2014 Annual Conference, 5-7 December, 2014, Brisbane, Australia (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Nash RE; Holmes SE

2014Woodward Sophie, Bereznicki BJ, Westbury JL, Bereznicki LRE, 'The effect of knowledge and expectations on adherence to and persistence with antidepressants', APSA 2014 Annual Conference, 5-7 December, 2014, Brisbane, Australia (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Bereznicki BJ; Westbury JL

2014Chalmers L, Nash RE, Holmes SE, Bereznicki LRE, Rasiah Rohan, et al., 'Development of a benchmarking tool for pharmacy students using threshold learning outcomes', Teaching Matters 2014, 2-3 December, 2014, Hobart, Tasmania (2014) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Nash RE; Holmes SE; Rasiah Rohan

2011Bereznicki LRE, 'Point of Care INR Monitoring', Pharmacy Expo 2011 catalogue, 17-19 June 2011, Darling Harbour NSW, Australia, pp. 29. ISBN 0 000 00000 0 (2011) [Plenary Presentation]

[eCite] [Details]

2011Bereznicki LRE, Chalmers L, Van Tienen EC, 'The current status of veterans taking warfarin', not known, 30 October- 2 November, Sydney NSW Australia, pp. 145. (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Chalmers L; Van Tienen EC

2011Bereznicki LRE, 'Atrial fibrillation: keeping the beat', Pharmacy Expo 2011 catalogue, 17-19 June 2011, Darling Harbour NSW, Australia, pp. 28. ISBN 0 000 00000 0 (2011) [Plenary Presentation]

[eCite] [Details]

2011Norton L, Bereznicki BJ, Bereznicki LRE, Beggs S, 'A review of the management of childhood asthma in Tasmania', APSA 2011 Annual Conference, 11-14 December, 2011, Adelaide, Australia (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Bereznicki BJ; Beggs S

2011Stafford L, Bereznicki LRE, Wang G, 'Barriers to INR self-monitoring in mechanical heart valve recipients: a qualitative study', Medicines Management Conference Handbook 2011, 10-13 November 2011, Hobart Tasmania Australia, pp. 169. (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L

2011Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, 'Clinical outcomes of a pharmacist-led post-discharge warfarin management service', Proceedings of the 11th national conference on anticoagulant therapy, 5-7 May 2011, Sheraton Boston Hotel, Boston, MA, USA, pp. 370. (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Jackson SL

2011Van Tienen EC, Stafford L, Bereznicki LRE, Peterson GM, 'Patient self-monitoring of anticoagulation: a follow-up study', Proceeding of the 11th national conference on anticoagulant therapy, 5-7 May 2011, Sheraton Boston Hotel, Boston, MA , pp. 382. (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Van Tienen EC; Stafford L; Peterson GM

2011McNamara K, Stewart K, George J, Jackson SL, Peterson GM, et al., 'Efficacy of a Pharmacist-Managed Intervention for Improved Blood Pressure Control in Patients with Elevated Cardiovascular Disease Risk: Subgroup Analysis of the HAPPY RCT', Heart Lung and Circulation, 11-14 August 2011, Perth, Australia, pp. 54. ISBN 0-000-00000-0 (2011) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Gee PR

2010Bereznicki LRE, 'Practical aspects of anti-platelet therapy', AACP's 6th annual consultant pharmacy clinical seminar handbook, 29-31 May 2010, The Hotel Grand Chancellor Hobart Tasmania (2010) [Conference Extract]

[eCite] [Details]

2010Bereznicki LRE, 'INR and practical patient care', Pharmacy Expo 2010 Catalogue, 4-6 June 2010, Sydney Convention and Exhibition Centre, Sydney, pp. 23. (2010) [Conference Extract]

[eCite] [Details]

2010Bereznicki LRE, 'Pharmacy based model enabling patient self monitoring of warfarin: Development and evaluation', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 10. (2010) [Conference Extract]

[eCite] [Details]

2010Bereznicki LRE, 'Outcomes of a Pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 77. (2010) [Conference Extract]

[eCite] [Details]

2010Bereznicki LRE, 'Consumers' perceptions of a pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 78. (2010) [Conference Extract]

[eCite] [Details]

2010Bereznicki LRE, 'Attempting to change practice: challenges and rewards', The 36th SHPA National Conference 2010 handbook, 11-14 November 2010, Melbourne Convention Exhibition Centre, pp. 83. (2010) [Conference Extract]

[eCite] [Details]

2010George J, McNamara K, Jackson SL, Hughes J, Peterson GM, et al., 'The HAPPY Trial: a community pharmacy - based intervention for improving patient adherence to antihypertensive medicines', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 79. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Gee PR

2010Jackson SL, Peterson GM, Bereznicki LRE, Gee PR, 'Hypertension adherence program in pharmacy (HAPPY Trial): Methodology', Pharmacy Practice Research Summit 2010, 2-4 March 2010, Rydges Lakeside, Canberra, pp. 18. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Gee PR

2010Jackson SL, Peterson GM, Bereznicki LRE, Gee PR, 'Hypertension adherence program in pharmacy (HAPPY trial): Baseline data', Pharmacy Practice Research Summit 2010, 2-4 March 2010, Rydges Lakeside, Canberra, pp. 18. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Gee PR

2010Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, Jupe D, et al., 'Ensuring accurate results in INR self-monitoring', Pathology The Journal of the Royal College of Pathologists of Australasia, 2010, Melbourne Convention Centre, pp. 70. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Jeffrey EC; Stafford L; Peterson GM

2010Mirkazemi C, Bereznicki LRE, Peterson GM, 'Thromboprophylaxis following arthroplasty surgery', 2010 National conference of emerging researchers in ageing abstracts and proceedings, 21-22 October 2010, Newcastle City Hall, pp. 41. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Mirkazemi C; Peterson GM

2010Mirkazemi C, Peterson GM, Bereznicki LRE, 'Thromboprophylaxis and venous thromboembolism following lower limb orthopaedic surgery at an Australian hospital', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 180. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Mirkazemi C; Peterson GM

2010Peterson GM, Stafford L, Bereznicki LRE, Jackson SL, 'Short-term outcomes of usual care in patients taking warfarin after discharge from hospital', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 18. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Peterson GM; Stafford L; Jackson SL

2010Peterson GM, Stafford L, Bereznicki LRE, van Tienen EC, Jackson SL, 'The role of community pharmacy in post hospital management of patients initiated on warfarin', Pharmacy Practice Research Summit Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 14. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Peterson GM; Stafford L; van Tienen EC; Jackson SL

2010Stafford L, DeBoos I, Peterson GM, Bajorek B, Jackson SL, et al., 'A qualitative analysis of warfarin management after discharge from hospital', Pharmacy Practice Research Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra , pp. 18. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Jackson SL

2010Stafford L, Peterson GM, Bereznicki LRE, 'Outcomes of a pharmacist-led post discharge warfarin management service: adverse events, warfarin knowledge and patient satisfaction', SEiR 2010 Postgraduate Research Conference booklet, 16-17 November 2010, University of Tasmania, Hobart Tasmania, pp. 32. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM

2010Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Jainullabudeen TA, et al., 'Clinical outcomes and cost-effectiveness of a pharmacy-led post-discharge warfarin management service', Proceeding of the Australasian Pharmaceutical Science Association Annual Conference 2010, 6-9 December 2010, Woolloongabba, QLD, pp. 81. ISBN 978-0-646-54805-0 (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Jackson SL; Bindoff IK

2010Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, van Tienen EC, et al., 'How can pharmacists improve warfarin management along the continuum of care?', The 36th SHPA National Conference 2010 handbook, 11-14 November 2010, Melbourne Convention Exhibition Centre, pp. 196. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Jackson SL; van Tienen EC

2010Stafford L, Peterson GM, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Consumers' perceptions of a pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress 2010 - Program handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 78. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Van Tienen EC; Jackson SL

2010Stafford L, Peterson GM, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Outcomes of a pharmacist-led post-discharge warfarin management service', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 77. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Van Tienen EC; Jackson SL

2010Stafford L, Peterson GM, Bereznicki LRE, van Tienen EC, Jackson SL, 'Outcomes of a pharmacist-led post-discharge warfarin management service adverse events, warfarin knowledge and patient satisfaction', Society of Hospital Pharmacists of Australia 2010 Tasmanian Branch Symposium, 21-23 May 2010, Port Arthur, Tasmania (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; van Tienen EC; Jackson SL

2010Stafford L, Peterson GM, Bereznicki LRE, van Tienen EC, Jackson SL, 'Outcomes of a pharmacist-led post-discharge warfarin management service', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 194. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; van Tienen EC; Jackson SL

2010Stafford L, Peterson GM, Bereznicki LRE, van Tienen EC, Jackson SL, 'Consumers' perceptions of a pharmacist-led post-discharge warfarin management service', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 265. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; van Tienen EC; Jackson SL

2010Van Tienen EC, Bereznicki LRE, Peterson GM, 'A flexible anticoagulation monitoring service for rural community pharmacies: A pilot study', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 77. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Van Tienen EC; Peterson GM

2010Van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Development of www.anticoagulation.com.au - A resource for anticoagulation therapy', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 76. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Van Tienen EC; Stafford L; Peterson GM

2010Van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Consumer perspectives on INR self-monitoring', Pharmacy Australia Congress 2010 - Program Handbook, 28-31 October 2010, Melbourne Convention Exhibition Centre, pp. 76. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: Van Tienen EC; Stafford L; Peterson GM

2010van Tienen EC, Bereznicki LRE, Peterson GM, 'A flexible anticoagulation monitoring service for rural community pharmacies: a pilot study', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 272. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Peterson GM

2010van Tienen EC, Bereznicki LRE, Peterson GM, 'Development of wwww.anticoagulation.com.au - a resource for anticoagulation therapy', Pharmacy Practice Reseach Summit 2010 Program, 2-4 March 2010, Rydges Lakeside Canberra, pp. 19. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Peterson GM

2010van Tienen EC, Bereznicki LRE, Peterson GM, Stafford L, 'Evaluation of a clinical pathway to enable patient self-monitoring of warfarin', Pharmacy Practice Reseach Summit 2010 Program, 2-4 march 2010, Rydges lakeside Canberra, pp. 19. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Peterson GM; Stafford L

2010van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation ', National Medicines Symposium 2010 final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 77. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Stafford L; Peterson GM

2010van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Consumer perspectives on INR self-monitoring', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 270. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Stafford L; Peterson GM

2010van Tienen EC, Bereznicki LRE, Stafford L, Peterson GM, 'Development of www.anticoagulation.com.au - a resource for anticoagulation therapy', National Medicines Symposium 2010. Medicines in people's lives - Final program and abstract book, 26-28 May 2010 , Melbourne Convention and Exhibition Centre, pp. 271. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Stafford L; Peterson GM

2010van Tienen EC, Stafford L, Bereznicki LRE, Peterson GM, 'Patient self-monitoring of anticoagulation: a follow up study', HAA Annual Scientific Meeting Handbook and Programme, 17-20 October, Sky City Convention Centre, pp. A235. (2010) [Conference Extract]

[eCite] [Details]

Co-authors: van Tienen EC; Stafford L; Peterson GM

2009Stafford L, Peterson GM, Bereznicki LRE, Van Tienen EC, Jackson SL, 'Early outcomes of a pharmacist-led post-discharge warfarin management service', The Australasian Pharmaceutical Science Association Annual Conference Program and Abstract Booklet , 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 81. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Van Tienen EC; Jackson SL

2009Bereznicki LRE, 'Antithrombotics: How pharmacists can optimise outcomes', Pharmacy Expo 2009 Catalogue, 12-14 June 2009, Sydney Convention and Exhibition Centre, Sydney, pp. 19. (2009) [Conference Extract]

[eCite] [Details]

2009Bereznicki LRE, 'Therapeutic Update: Warfarin', The AACP Accredited Pharmacists Forum 2009, 15-18 October 2009, Sydney Hilton, Sydney Australia, pp. xx-xx. (2009) [Conference Extract]

[eCite] [Details]

2009Bereznicki LRE, 'How can pharmacists improve the management of warfarin therapy?', In: APSA 2009 : Out of the wilderness : Proceedings of the Australasian Pharmaceutical Science Association annual conference 2009 , 9 - 11 December 2009, Wrest Point Convention Centre, Hobart Tasmania, pp. 62. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

2009Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, 'Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation', HAA handbook and final programme, 19-21 October, Adelaide Australia, pp. 276. (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Jeffrey EC; Stafford L; Peterson GM

2009Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, 'Refinement of an innovative web-based anticoagulation resource', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, pp. 73. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Jeffrey EC; Stafford L; Peterson GM

2009Jeffrey EC, Bereznicki LRE, Stafford L, Peterson GM, 'Evaluation of a clinical pathway to enable patient self-monitoring of anticoagulation', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 153. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Jeffrey EC; Stafford L; Peterson GM

2009Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, 'Characteristics and short-term outcomes of Royal Hobart Hospital patients discharged on warfarin', Society of Hospital Pharmacists of Australia, Tasmanian Branch, Symposium 2009, 22-24 May 2009, Grindelwald, Tasmania (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Jackson SL

2009Stafford L, Peterson GM, Bereznicki LRE, Jackson SL, Bajorek B, et al., 'More blood, sweat and tears: a qualitative analysis of warfarin management after discharge from hospital', SHPA 35th National Conference Handbook and book of abstracts, 5-8 November 2009, Perth Convention Exhibition Centre WA, pp. 184. (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Stafford L; Peterson GM; Jackson SL

2009Bereznicki LRE, 'Anticoagulation patient self-monitoring', The Pharmacy Australia Congress Program Handbook, 15-18 October 2009, The Sydney Hilton, Sydney Australia, pp. 64. (2009) [Conference Extract]

[eCite] [Details]

2009Williams Mackenzie, Peterson GM, Tenni PC, Bereznicki LRE, 'Identifying barriers to the implementation of an electronic system designed for documenting clinical interventions within community pharmacies ', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet, 9-11 December 2009, Wrest Point Convention Centre, Hobart, Tasmania, pp. 176. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Williams Mackenzie; Peterson GM; Tenni PC

2009Williams Mackenzie, Peterson GM, Tenni PC, Bereznicki LRE, 'Refinement of the design of an electronic system to record community pharmacy interventions', Out of the Wilderness - 2009 APSA Annual Conference program and abstracts booklet , 9-11 December 2009 , Wrest Point Convention Centre, Hobart, Tasmania , pp. 175. ISBN 978-0-646-52257-9 (2009) [Conference Extract]

[eCite] [Details]

Co-authors: Williams Mackenzie; Peterson GM; Tenni PC

2009Bereznicki LRE, 'INR point of care testing', The Australian Institute of Medical Scientists, 8-9 August 2009, The Colonial on Elizabeth, Launceston, pp. 6. (2009) [Conference Extract]

[eCite] [Details]

2008Bereznicki LRE, 'Innovative communication strategies to manage chronic disease or high-risk medications', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 29. (2008) [Conference Extract]

[eCite] [Details]

2008Bereznicki LRE, Peterson GM, Krog M, La Rosa T, Marsden KA, et al., 'The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 96. (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Peterson GM; Krog M; La Rosa T; Marsden KA; Lowenthal RM

2008Bereznicki LRE, Peterson GM, Krog M, La Rosa T, Marsden KM, 'The risk of symptomatic venous thromboembolism in hospitalised patients with active cancer', Teams for tomorrow, 6-9 December 2008, Canberra, ACT, pp. 108. (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Peterson GM; Krog M; La Rosa T; Marsden KM

2008Jackson SL, Bereznicki LRE, Gee PR, Fitzmaurice KD, Kromdijk W, et al., 'Innovative IT solutions to improve the management of warfarin', QUM - what does it really mean for you? The science, the policy and the practice. Final Program and Abstract Book., 14-16 May 2008, National Convention Centre, Canberra, Australia, pp. 60. (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Gee PR; Fitzmaurice KD; Kromdijk W; Bereznicki BJ; Marsden KA

2008Jeffrey EC, Bereznicki LRE, Peterson GM, Jackson SL, 'Development of an innovative web based anticoagulation resource', Teams for tomorrow - Proceedings of the APSA (Australasian Pharmaceutical Science Association), 6-9 December 2008, Canberra, ACT, pp. 108. ISBN 0-646-44244-9 (2008) [Conference Extract]

[eCite] [Details]

Co-authors: Jeffrey EC; Peterson GM; Jackson SL

2007Bereznicki LRE, 'New Investigator Presentations: Improving the quality use of anticoagulants', Pharmacy Congress: Good Pharmacy , Better Health & health Industry Forum Program and Handbook, 23-26 August 2007, Melbourne, Aust, pp. 60. (2007) [Conference Extract]

[eCite] [Details]

2007Bereznicki LRE, 'A pilot study of warfarin home monitoring with electronic communication to primary care', Australian Disease Management Association Full Program, 6-7 September 2007, Melbourne, Aust, pp. 20. (2007) [Conference Extract]

[eCite] [Details]

2007Bereznicki LRE, Jackson SL, Peterson GM, 'A pilot study of warfarin home-monitoring with electronic communication to primary care', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2007Bereznicki LRE, Jackson SL, Ripley A, 'INR Self Monitoring Training Workshop', INR Self Monitoring Training Workshop, 3 June 2007, Sunshine Coast, Qld, Aust, pp. 200. (2007) [Non Refereed Conference Paper]

[eCite] [Details]

Co-authors: Jackson SL

2007Peterson GM, Jackson SL, Gee PR, Bereznicki LRE, Bereznicki BJ, et al., 'Improving the management of warfarin in aged care facilities utilising an innovative IT solution', Australian Pharmaceutical Science Association, 8-11 December 2007, Manly NSW, pp. 205. ISBN 978-0-646-48458-7 (2007) [Conference Edited]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL; Gee PR; Bereznicki BJ; Fitzmaurice KD; Kromdijk W

2006Bereznicki LRE, 'An intervention to improve clinical outcomes for inpatients commenced on warfarin', The Society of Hospital Pharmacists of Australia Program Handbook, 9-11 November 2006, Telstra Dome Melbourne, pp. 88. (2006) [Conference Extract]

[eCite] [Details]

2006Bereznicki LRE, Burbury K, Jupe DM, Marsden KA, Hancock N, et al., 'Improving the use of prophylaxis for venous thromboembolism at the Royal Hobart Hospital', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 50. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Vial JH

2006Bereznicki LRE, Jackson SL, Boland C, Marsden KA, Voute J, et al., 'An intervention to improve adherence to an initiation protocol and improve clinical outcomes for patients commenced on warfarin', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 36. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Vial JH; Peterson GM

2006Bereznicki LRE, Jackson SL, Peterson GM, Jeffrey EC, Leong K, et al., 'The warfarin home-monitoring pilot study', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 35. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Jeffrey EC

2006Peterson GM, Jackson SL, Tompson AJ, Bereznicki LRE, 'An evaluation of pharmacist-assisted anticoagulant monitoring after initiation of warfarin in the transition from hospital to community care', Final Program and Abstract Book, 07-09 June 2006, National Convention Centre, Canberra, Australia, pp. 36. (2006) [Conference Extract]

[eCite] [Details]

Co-authors: Peterson GM; Jackson SL; Tompson AJ

2006Bereznicki LRE, 'Thromboprophylaxis in medical patients', The Society of Hospital Pharmacists of Australia Program Handbook, 9-11 November 2006, Telstra Dome Melbourne, pp. 38. (2006) [Conference Extract]

[eCite] [Details]

2005Bereznicki LRE, Jackson SL, Vlassak E, Burbury K, Marsden KM, et al., 'The use of thromboprophylaxis for venous thromboembolism (VTE) in hospitalised medical patients', HSANZ/ANZSBT/ASTH Annual Scientific Meeting, 16-19 October 2005, Sydney Convention and Exhibition Centre, Darling H, pp. 107. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Vlassak E; Peterson GM

2005Bereznicki LRE, Vlassak E, Peterson GM, Jackson SL, Marsden K, et al., 'The use of thromboprophylaxis for venous thromboembolism in hospitalised medical patients at the Royal Hobart Hospital', SHPA 2005 Conference Program, 1-3 April 2005, St Helens, Tasmania, pp. 24. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Vlassak E; Peterson GM; Jackson SL; Vial JH

2005Boland C, Aldous D, Bereznicki LRE, Vial JH, Marsden K, et al., 'Reducing harm associated with warfarin therapy: a national medication safety collaborative project', Conference Handbook and Proceedings, 10-13 November 2005, Brisbane, Qld, pp. 87. ISSN 1833-0169 (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Vial JH

2005Boland C, Aldous D, Bereznicki LRE, Vial JH, Marsden KM, et al., 'Reducing harm associated with warfarin therapy. A national medication safety breakthrough project', SHPA 2005 Conference Program, 1-3 April 2005, St Helens, Tasmania, pp. 24. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Vial JH; Marsden KM

2005Jackson SL, Bereznicki LRE, Peterson GM, Fitch J, Fowler P, 'Review of the initiation of warfarin in Tasmania', SHPA 2005 Conference Program, 1-3 April 2005, St Helens, Tasmania, pp. 24. (2005) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM

2004Jackson SL, Morgan S, Peterson GM, Bereznicki LRE, Jupe DML, et al., 'A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes?', Conference Handbook, 29-31 October 2004, Sydney, pp. 79. (2004) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Marsden KA

2004Jackson SL, Peterson GM, Morgan S, Bereznicki LRE, Jupe DML, 'A review of the initiation of anticoagulation: does lack of adherence to guidelines result in an increased risk of adverse outcomes?', Handbook and Final Programme. Advancing Haematology Through Science, 17-20 October 2004, Melbourne, Victoria, pp. 308. (2004) [Conference Extract]

[eCite] [Details]

Co-authors: Jackson SL; Peterson GM; Jupe DML

Thesis

(1 outputs)
YearCitationAltmetrics
2007Bereznicki LRE, 'Improving the quality use of anticoagulants' (2007) [PhD]

[eCite] [Details]

Grants & Funding

Funding Summary

Number of grants

35

Total funding

$6,903,653

Projects

Investigating the burden of childhood fever on Tasmanian families and the Royal Hobart Hospitals Emergency Department. (2016)$9,599
Description
This project will describe the presentations to the Royal Hobart Hospital emergency department by children with fever, investigate the knowledge, beliefs and perceptions about childhood fever among parents and caregivers in Tasmania, and develop an educational package for parents and caregivers about childhood fever.
Funding
Royal Hobart Hospital Research Foundation ($9,599)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Bereznicki BJ; Beggs S; Bereznicki LRE; Zosky GR
Year
2016
Pharmacy Oral Examination: Examiner Training Development (2015)$14,033
Description
This project will ensure that resources and training are provided for examiners to produce a reliable and consistent training process that will ensure candidates are reliably assessed on their ability to demonstrate that they can work safely, professionally and ethically unsupervised.
Funding
University of Newcastle ($14,033)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Bereznicki LRE; Chalmers L; Rasiah R; Cooper J
Year
2015
Development of a decision support smartphone app to improve antithrombotic prescribing in atrial fibrillation (2015)$12,000
Description
The objectives of this study are to:Develop and validate a decision support smartphone application (app) to support prescribers in the choice of thromboprophylaxis in patients with atrial fibrillation (AF),Evaluate the effect of the tool on prescriber confidence in choosing antithrombotic agents for patients with AF based on patient age, comorbidities, concomitant drug therapy and other characteristics, andEvaluate the effect of the tool on the prescribing patterns of antithrombotic therapy in patients admitted to the RHH with AF.
Funding
Royal Hobart Hospital Research Foundation ($12,000)
Scheme
Grant-Clinical Research
Administered By
University of Tasmania
Research Team
Chalmers L; Bereznicki LRE; Prasard R; Hancock N; MacIntyre P; McKenzie D; Boland C
Year
2015
Impact of community pharmacy services on screening for chronic kidney disease (2014)$26,775
Description
This project aims to investigate if community pharmacy screening and intervention helps improve the management of kidney disease, which has been increasing steadily in Tasmania.
Funding
Tasmanian Community Fund ($26,775)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Castelino RL; Peterson GM; Bereznicki LRE; Razi Zaidi ST; Jose MD
Year
2014
Educating Tasmanians about anticoagulant medications (2013)$10,435
Description
Atrial fibrillation (AF) is a common heart arrhythmia, which affects approximately 2% of all Australians, and almost 10% of people over the age of 75 years. AF is associated with a 5-fold increase in the risk of stroke. Anticoagulant therapies like warfarin, dabigatran, rivaroxaban and apixaban are highly effective in reducing the risk of stroke associated with AF, but also place patients at risk of bleeding adverse events. It is therefore critical that anticoagulant therapies are used appropriately in people with AF, to ensure that the right patients receive them and that the risk of bleeding is kept as low as possible. This project will enable Tasmanians taking anticoagulant therapy access to high quality, independent educational resources focussed on improving the use of this commonly used but high-risk group of medications. The project is focussed on developing educational resources for people taking the commonly used anticoagulant drug warfarin, and three new anticoagulant medications (dabigatran, rivaroxaban and apixaban). These medicines are used to prevent stroke in people with atrial fibrillation, as well as prevent and treat deep vein thrombosis and pulmonary embolism. Given the demographics of Tasmania's community, the use of these medicines and need for relevant educational support of consumers is highest in this State. The project will develop educational tools for consumers and health professionals, and promote these resources to general practices and community pharmacies.
Funding
Tasmanian Community Fund ($10,435)
Scheme
Grant
Administered By
University of Tasmania
Research Team
Bereznicki LRE; Chalmers L; Peterson GM; Van Tienen EC
Year
2013
Management of post-operative pain and the progression to persistent post-operative pain (2013)$8,634
Description
This project is a prospective, cross sectional study designed to ascertain patient or management factors that increase the risk of developing PPP, with the objective of designing a predictive model to identify high risk PPP candidates. PPP will be defined as pain at the surgical site 3 months after surgery, with severe pain being defined as 5 or more on a 10-point scale. The project involves recruitment of patients, surveys, medical chart data collection, inclusion criteria, exclusion criteria, sample size, data analysis, and assessment of variables.
Funding
Royal Hobart Hospital Research Foundation ($8,634)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Orlikowski C; Bereznicki LRE; Peterson GM; Thompson AJ; Veal FC
Year
2013
Warfarin Booklet Rewrite (2012)$1,680
Funding
Aspen Pharmacare Australia ($1,680)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Chalmers L
Year
2012
Fucoidan and marine polyphloroglucinols (2012 - 2014)$85,000
Description
Brown algal extracts, in particular those containing fucoidan and marine polyphloroglucinols, have been shown to have potential applications in a number of health indications such as pre-diabetes, immunomodulation, cardiovascular disease and inflammation. With advances in technology, fucoidan and marine polyphloroglucinol extracts from brown seaweed can now be produced successfully on a commercial scale. These types of extracts are beginning to become more prevalent as ingredients in western dietary supplement markets. However, for the extracts to successfully enter this market, efficacy, safety and provenance must be proven. With this in mind, the objectives of this PhD project include the following: to establish a generic analytical method that can be used to fingerprint and quantify fucoidan concentrations in solution, serum and urine; to determine the ability of a commercially available fucoidan/polyphloroglucinol extract (Maritech Synergy) to inhibit the uptake of glucose via an acute human study; to assess the effects of Maritech Synergy on health indications including glucose control, insulin sensitivity and pre-diabetes in a human setting; and to further the understanding of fucoidan and its metabolism.
Funding
Marinova Pty Ltd ($85,000)
Scheme
Clinical Trial
Administered By
University of Tasmania
Research Team
Peterson GM; Patel RP; Bereznicki LRE
Period
2012 - 2014
Adverse Drug Reactions as a Cause of Hospital Admission in the Elderly (2012)$13,000
Funding
University of Tasmania ($13,000)
Scheme
Grant-Research Enhancement (REGS)
Administered By
University of Tasmania
Research Team
Bereznicki LRE; Chalmers L; Jose MD
Year
2012
Outcomes of antithrombotic therapy in a new era: the Tasmanian experience (2012 - 2013)$12,545
Funding
Royal Hobart Hospital Research Foundation ($12,545)
Scheme
Grant-Research
Administered By
University of Tasmania
Research Team
Chalmers L; Bereznicki LRE; Peterson GM; Hancock N; Roberts-Thomson P
Period
2012 - 2013
A Review of the Management of Childhood Asthma in Tasmania (2011)$5,500
Funding
Asthma Foundation of Tasmania ($5,500)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Bereznicki BJ; Bereznicki LRE
Year
2011
Clinical Interventions Workshop (2011)$49,075
Funding
Pharmaceutical Society of Australia ($49,075)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Thompson AJ
Year
2011
Warfarin Booklet Rewrite (2011)$7,890
Funding
Aspen Pharmacare Australia ($7,890)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Chalmers L
Year
2011
Clinical Interventions in Pharmacy Online Training Materials (2011)$10,000
Funding
Pharmaceutical Society of Australia ($10,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE
Year
2011
Medication Reviews ReDirected: Acute Coronary Syndromes as an Indication for Home Medicine Review, a randomised controlled trial (2011)$22,401
Funding
University of Tasmania ($22,401)
Scheme
Grant-Institutional Research Scheme
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Year
2011
Evidence to Practice Gap: Factors that Influence Practices to Prevent Blood Clots Following Hip and Knee Replacement Surgery (2011)$4,545
Funding
Royal Hobart Hospital Research Foundation ($4,545)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Hansen EC; Mirkazemi C
Year
2011
Factors Influencing the Outcomes of Therapy with the Anti-clotting medication, Clopidogrel, in Patients with Acute Coronary Syndromes (2011)$4,545
Funding
Royal Hobart Hospital Research Foundation ($4,545)
Scheme
Grant-Starter
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Vonna A; Chalmers L; Van Tienen EC; Roberts-Thomson P; Piatkov I
Year
2011
Development and Maintenance of an Online Resource - Anticoagulation (Phase 2) (2010)$57,299
Funding
Roche Diagnostics Australia Pty Limited ($57,299)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Year
2010
Alternative Methods of Confirming HbA1c (2010)$148,660
Funding
Pharmacy Guild Australia ($148,660)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Clifford R; Gudka S
Year
2010
Review of APF 22 (2010)$3,000
Funding
Pharmaceutical Society of Australia ($3,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Thompson AJ
Year
2010
Professional Practice Standards and Practice Guidelines for Clinical Interventions (2010)$33,728
Funding
Pharmaceutical Society of Australia ($33,728)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Bereznicki LRE; Bindoff IK; Spiller CJ
Year
2010
The Current Status of Management of Australian Veterans Taking Warfarin (2010)$31,779
Funding
Commonwealth Department of Veterans Affairs ($31,779)
Scheme
Grant-Applied Research Program
Administered By
University of Tasmania
Research Team
Bereznicki LRE; Stafford AC; Van Tienen EC
Year
2010
Persistence with and Attitudes Towards INR Self-Monitoring Following Mechanical Heart Valve Insertion: Informing the Development of a Structured Training Program (2010)$17,980
Funding
University of Tasmania ($17,980)
Scheme
Grant-Institutional Research Scheme
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Year
2010
Rising Star (2010 - 2012)$74,124
Funding
University of Tasmania ($74,124)
Scheme
Grant-Rising Stars Round 2
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Period
2010 - 2012
Development of a Smoking Cessation Educational Program for Pharmacists and Pharmacy Assistants (2009)$6,415
Funding
Pharmaceutical Society of Australia, Tasmanian Branch ($6,415)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Year
2009
Development and Maintenance of an Online Resource - Anticoagulation (Phase 1) (2009)$25,000
Funding
Roche Diagnostics Australia Pty Limited ($25,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Year
2009
Development and Implementation of a Flexible Anticoagulation Monitoring Service for Rural Community Pharmacies (2009 - 2010)$19,125
Funding
Department of Health and Ageing ($19,125)
Scheme
Grant-Small Projects Scheme
Administered By
University of Tasmania
Research Team
Bereznicki LRE; Van Tienen EC; Peterson GM
Period
2009 - 2010
Supporting Rural Practitioners: Pharmacy-based Support Mechanisms for Drug Misuse in Rural and Remote Communities (2009)$19,735
Funding
Department of Health and Ageing ($19,735)
Scheme
Grant-Small Projects Scheme
Administered By
University of Tasmania
Research Team
Peterson GM; Law K; Jackson SL; Fitzmaurice KD; Bereznicki LRE; Sutherland P; Howarth H
Year
2009
Pharmacy-Based Model Enabling Patient Self-Monitoring of Warfarin: Development and Evaluation (2008 - 2009)$198,603
Funding
Department of Health and Ageing ($198,603)
Scheme
Grant-PGA Pharmacy Guild-Investigator Initiated
Administered By
University of Tasmania
Research Team
Bereznicki LRE; Peterson GM; Jackson SL; McLachlan AJ; Bajorek BV; Nelson MR; Marsden KA; Kelly B; Fitzmaurice KD; Gee PR
Period
2008 - 2009
The Role of Community Pharmacy in Post Hospital Management of Patients Initiated on Warfarin (2008 - 2010)$1,236,174
Funding
Department of Health and Ageing ($1,236,174)
Scheme
Tender-Warfarin
Administered By
University of Tasmania
Research Team
Peterson GM; Jackson SL; Bereznicki LRE; Nelson MR; Angley M; Mullan J; Gaetini L; Misan G
Period
2008 - 2010
Documenting Clinical Interventions in Community Pharmacy - PROMISE 3 (2008 - 2010)$3,248,448
Funding
Department of Health and Ageing ($3,248,448)
Scheme
Tender
Administered By
University of Tasmania
Research Team
Peterson GM; Tenni PC; Bereznicki LRE; Jackson SL; Kong D; Hughes Jeff
Period
2008 - 2010
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease (2008 - 2010)$1,246,926
Funding
Department of Health and Ageing ($1,246,926)
Scheme
Tender
Administered By
Monash University
Research Team
Stewart K; George J; Jackson SL; Peterson GM; Hughes Jeff; McNamara K; Bailey M; Hsueh A; McDowell J; Bereznicki LRE; Gee PR
Period
2008 - 2010
Pharmaceutical Society of Australia Co-funded Scholarship (2007 - 2009)$10,000
Funding
Pharmaceutical Society of Australia ($10,000)
Scheme
Donation - Institutional
Administered By
University of Tasmania
Research Team
Bereznicki LRE
Period
2007 - 2009
DVT Prophylaxis Study (2006)$30,000
Funding
Sanofi~Synthelabo Australia Pty Ltd ($30,000)
Scheme
Consultancy
Administered By
University of Tasmania
Research Team
Peterson GM; Jackson SL; Bereznicki LRE
Year
2006
Improving the management of warfarin in aged care facilities utilising an innovative ICT solution (2006 - 2007)$199,000
Funding
Department of Health and Human Services Tasmania ($199,000)
Scheme
Contract Research
Administered By
University of Tasmania
Research Team
Peterson GM; Jackson SL; Bereznicki LRE
Period
2006 - 2007

Research Supervision

Current

11

Completed

4

Current

DegreeTitleCommenced
PhDGenetic Resistance to Treatment with Clopidogrel2011
PhDThe Pharmacological Management of Pain in Older Australians2012
PhDAntiretroviral Adherence and Treatment Outcomes Among Adult Ethiopian Patients2012
PhDA Prospective Study on Nature and Pattern of the Occurence of Adverse Drug Events with the Use of Cardiovascular Drugs2012
MastersAn Investigation of the Significant Role of Pharmacists in Improving the Quality of Palliative Care Service in North West Tasmania2013
PhDA Retrospective Study of Adverse Drug Reactions Occurring in Elderly Patients at Tertiary Hospitals, Tasmania, Australia2013
PhDCommunity Pharmacy Screening and Medication Management in Chronic Kidney Disease2014
PhDMedication Errors and Adverse Drug Events among Hospitalized Pediatrics Patients: Incidence, Determinants and Interventions2014
PhDMultiple Anti-thrombotic Medication Use, Associated Risks of Bleeding and Thrombosis in Tasmanian Patients: Prospective Follow-up Study2014
PhDEffective Use of Antithrombotics in the Prevention of Atrial Fibrillation Related Stroke2014
PhDThe Optimisation of Antithrombotic Therapy for Atrial Fibrillation Using Decision Support Tools2015

Completed

DegreeTitleCompleted
PhDThromboprophylaxis Following Hip and Knee Arthroplasty
Candidate: Corinne Mirkazemi
2013
MastersThe Outcomes of Clopidogrel Therapy in Patients with ACS in Southern Tasmania
Candidate: Azizah Vonna
2013
PhDOptimising Warfarin Management: An Exploration of Pharmacist-delivered Models of Care
Candidate: Ella Claire van Tienen
2012
PhDThe Role of Community Pharmacy in Post-Discharge Warfarin Management
Candidate: Leanne Chalmers
2012